These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 37392848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.
    Lopez JR, Kaura V, Diggle CP, Hopkins PM, Allen PD.
    Br J Anaesth; 2018 Oct; 121(4):953-961. PubMed ID: 30236258
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.
    Truong KM, Pessah IN.
    Toxicol Sci; 2019 Feb 01; 167(2):509-523. PubMed ID: 30329129
    [Abstract] [Full Text] [Related]

  • 6. A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.
    Estève E, Eltit JM, Bannister RA, Liu K, Pessah IN, Beam KG, Allen PD, López JR.
    J Gen Physiol; 2010 Jun 01; 135(6):619-28. PubMed ID: 20479110
    [Abstract] [Full Text] [Related]

  • 7. A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels.
    Bannister RA, Estève E, Eltit JM, Pessah IN, Allen PD, López JR, Beam KG.
    J Gen Physiol; 2010 Jun 01; 135(6):629-40. PubMed ID: 20479108
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
    Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, Pessah IN, Lopez JR.
    Anesthesiology; 2006 Dec 01; 105(6):1164-75. PubMed ID: 17122579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impaired interaction between skeletal ryanodine receptors in malignant hyperthermia.
    Liang X, Chen K, Fruen B, Hu J, Ma J, Hu X, Parness J.
    Integr Biol (Camb); 2009 Sep 01; 1(8-9):533-9. PubMed ID: 20023768
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities.
    Lopez RJ, Byrne S, Vukcevic M, Sekulic-Jablanovic M, Xu L, Brink M, Alamelu J, Voermans N, Snoeck M, Clement E, Muntoni F, Zhou H, Radunovic A, Mohammed S, Wraige E, Zorzato F, Treves S, Jungbluth H.
    Sci Signal; 2016 Jul 05; 9(435):ra68. PubMed ID: 27382027
    [Abstract] [Full Text] [Related]

  • 17. Molecular Modification of Transient Receptor Potential Canonical 6 Channels Modulates Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia.
    Lopez JR, Uryash A, Adams J, Hopkins PM, Allen PD.
    Anesthesiology; 2021 Feb 01; 134(2):234-247. PubMed ID: 33301562
    [Abstract] [Full Text] [Related]

  • 18. Voltage modulates halothane-triggered Ca2+ release in malignant hyperthermia-susceptible muscle.
    Zullo A, Textor M, Elischer P, Mall S, Alt A, Klingler W, Melzer W.
    J Gen Physiol; 2018 Jan 02; 150(1):111-125. PubMed ID: 29247050
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.